JP Morgan Healthcare Conference, Day Three: Foundation Medicine, Luminex, PerkinElmer, Danaher, Quidel, Ariosa, BioFire, Atossa, Exact Sciences | GenomeWeb

This story has been updated from a previous version to clarify Exact Sciences' FDA submission timeline.

SAN FRANCISCO (GenomeWeb News) – The third day of this year's JP Morgan Healthcare Conference featured presentations from a number of molecular diagnostics and life science tool companies covered by GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.